<DOC>
	<DOCNO>NCT00677768</DOCNO>
	<brief_summary>The purpose study collect 650 blood 300 cerebrospinal fluid ( CSF ) sample people amyotrophic lateral sclerosis ( ALS ) , pure low upper motor neuron disease , well neurodegenerative disease people neurological disorder . Through comparison sample , researcher hope learn underlie cause ALS , well find unique biological marker , could use diagnose ALS monitor disease progression . Additionally , 600 blood sample collect sub-study DNA analysis . Studying component blood , DNA , may help u understand happen gene function abnormally might relate disease .</brief_summary>
	<brief_title>Validation Biomarkers Amyotrophic Lateral Sclerosis ( ALS )</brief_title>
	<detailed_description>Researchers test change happen volunteer ALS see blood change unique ALS different find healthy volunteer volunteer neurological disease ALS . These change call biomarkers . Biomarkers ALS find blood collect earlier phase study . Biomarkers non-genetic element blood may help make diagnose ALS easy . In next phase , comparison change blood volunteer ALS without ALS use confirm biomarkers develop tool diagnose monitor progression ALS .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Paraparesis</mesh_term>
	<mesh_term>Paraparesis , Spastic</mesh_term>
	<criteria>1 . ALS Volunteers Diagnosis possible ( exclude volunteer UMN sign ONLY ) , probable , probablelaboratory support , definite ALS , either sporadic familial accord revise El Escorial criterion Disease duration less equal two year symptom onset Age 3080 year time disease onset Ability provide inform consent Ability comply study procedure Medically safe lumbar puncture ( lumbar puncture volunteer ) Clinical evidence chronic liver renal failure Presence bleeding disorder , problem CSF pressure , allergy local anesthetic , topical skin infection LP site ( lumbar puncture volunteer ) Use antiplatelet anticoagulant drug , plavix , aggrenox , ticlid , warfarin coumadin ( lumbar puncture volunteer ) 2 . Suspected ALS ( PMND ) Volunteers Diagnosis suspect ALS define presence UMN LMN sign alone diagnosis Clinically Probably LaboratorySupported ALS CAN NOT prove evidence clinical ground conjunction electrodiagnostic , neurophysiologic , neuroimaging clinically laboratory study Disease duration less equal four year symptom onset Age 3080 year time disease onset Ability provide inform consent Ability comply study procedure Medically safe lumbar puncture ( lumbar puncture volunteer ) Clinical evidence chronic liver renal failure Genetically confirm diagnosis hereditary spastic paraparesis spinal motor atrophy ( SMA ) disease Presence bleeding disorder , problem CSF pressure , allergy local anesthetic , topical skin infection LP site ( lumbar puncture volunteer ) Use antiplatelet anticoagulant drug , plavix , aggrenox , ticlid , warfarin coumadin ( lumbar puncture volunteer ) 3 . Neurological Disease Mimic Volunteers Diagnosis one following : Pure Lower Motor Neuron Disease ( LMND ) mimic : Multifocal motor neuropathy Autoimmune motor neuropathy Cervical lumbosacral radiculopathies Peripheral mononeuropathy : Ulnar neuropathy Carpal tunnel syndrome/median neuropathy Peroneal neuropathy Sciatic neuropathy Spinal muscular atrophy Spinobulbar muscular atrophy ( Kennedy 's disease ) Charcot MarieTooth Disease ( CMT ) Pure Upper Motor Neuron Disease ( UMND ) mimic : Cervical myelopathy Multiple sclerosis Hereditary spastic paraparesis Age 3080 year Ability provide inform consent Ability comply study procedure Medically safe lumbar puncture ( lumbar puncture volunteer ) Diagnosis suspect , possible , probable definite ALS either sporadic familial Presence positive family history ALS Clinical evidence chronic renal liver failure Presence bleeding disorder , problem CSF pressure , allergy local anesthetic , topical skin infection LP site ( lumbar puncture volunteer ) Use antiplatelet anticoagulant drug , plavix , aggrenox , ticlid , warfarin coumadin ( lumbar puncture volunteer ) 4 . Healthy Control Volunteers Inclusion Criteria Absence know neurological disorder . Age 30 80 year . Ability provide inform consent . Ability comply study procedure . Medically safe lumbar puncture . History ALS , myopathy , neuropathy , ALS mimic disorder neurodegenerative disease . Presence positive family history ALS . Clinical evidence chronic liver renal failure . Presence bleed disorder , problem CSF pressure , allergy local anesthetic , topical skin infection LP site ( LP research volunteer ) . Research participant must take antiplatelet anticoagulant drug , plavix , aggrenox , ticlid , warfarin coumadin ( LP research volunteer ) .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Biomarkers</keyword>
	<keyword>Plasma</keyword>
	<keyword>Cerebrospinal Fluid</keyword>
	<keyword>DNA</keyword>
	<keyword>Serum</keyword>
</DOC>